Commentary to: Cancer and treatment specific incidence rates of immune related adverse events induced by immune checkpoint inhibitors: a systematic review
Br J Cancer. 2024 Dec 16.
doi: 10.1038/s41416-024-02933-y.
Online ahead of print.
1 Oral Medicine, Oral Oncology and Dentistry, Miami Cancer Institute, Baptist Health South Florida, Miami, FL, USA. Alessandro.villa@baptisthealth.net.
2 Department of Orofacial Sciences, School of Dentistry, University of California San Francisco, San Francisco, CA, USA. Alessandro.villa@baptisthealth.net.
3 University of Michigan Health System, Ann Arbor, MI, USA.
4 American Society of Clinical Oncology, Alexandria, VA, USA.
5 School of Dental Medicine, UConn Health, Farmington, CT, USA.